对于化封装的以体纳米载体:配方优化,稳定性和体外释放性能
Yasemin Yağan Uzuner1,2, Hakan Sevinç2,3, Zeynep Kanlidere4
1Department of Pharmaceutical Technology, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye.
Molecules (Basel, Switzerland)
|February 27, 2026
概括
人体纳米载体有效封装水解原蛋白 (HCP),增强其稳定性和控制释放,用于抗衰老皮肤治疗. 这种配方改善了这些关键皮肤化品成分的局部输送和生物可用性.
科学领域:
- 皮肤化品和纳米技术
- 生物材料科学 生物材料科学
- 配方化学 配方化学 配方化学
背景情况:
- 在抗衰老产品中,水解原 (HCP) 对于皮肤水分,弹性和细胞外基质完整性至关重要.
- HCP的高水友性阻碍了它们被纳入基于脂质的配方,并限制了受控释放.
- 开发先进的输送系统对于克服这些局限性来提高皮肤美容疗效至关重要.
研究的目的:
- 设计和优化以太体纳米载体,以改善封,稳定性和控制性释放水友性原蛋白 (HCP).
- 为了评估HCP载荷以体的物理化学特性和体外性能,用于皮肤美容应用.
- 研究以体作为增强原的局部生物可用性平台的潜力.
主要方法:
- 用脂和乙醇制备载有HCP的以体纳米载体,通过高压均质化进行优化.
- 描述包括囊泡大小,泽塔潜力,pH值,长期稳定性 (180天),形态 (冷-SEM) 和脂相互作用 (FTIR).
- 评估了封装效率,皮肤细胞细胞相容性 (HaCaT细胞) 和体外释放动力学 (弗朗兹扩散细胞).
主要成果:
- 经过优化后的以太体表现出纳米尺寸,高合稳定性和负泽塔电位 (-42.9至-76.7mV).
- 证实了持续的封装效率 (73%在180天后) 和保存的结构,表明有效的稳定.
- 在体外释放的研究显示,与自由的HCP相比,受控的,延长释放的特征,表明局部生物可用性增强和良好的皮肤细胞兼容性.
结论:
- 优化的人体系统有效地稳定水友性原蛋白,用于抗衰老的皮肤美容应用.
- 装有HCP的以索姆为生物活性保存,增强稳定性和受控的局部性能提供了一个有希望的配方平台.
- 这种方法促进了基于原的先进皮肤再生策略,提高了有效性和传递.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
269
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
269
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51


